Latest Diamyd Medical News & Updates

See the latest news and media coverage for Diamyd Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Diamyd Medical

Clinical-stage diabetes therapy developer

diamyd.com
Headquarters
Stockholm, Sweden
Company type
Public company
Number of employees
10–70

Last updated

Latest news about Diamyd Medical

In short: Diamyd Medical underwent a leadership overhaul and strategic review after its Phase 3 DIAGNODE-3 trial for type 1 diabetes failed to meet its goals.

Company announcements

Diamyd Medical

Diamyd Medical has received GMP approval for its Umeå facility

Sofia Mayans, Head of Manufacturing Site Umeå, calls it a major strength for the region.

Unlock all announcements with a

Media coverage

Dagens industri

Stock-crashed company looks beyond health sector

The diabetes research company Diamyd Medical, after the results from the Diagnode-3 study, will prioritize an orderly winding down of the Phase 3 program. It appears...

The Wall Street Journal

Diamyd Medical AB Series B

1 Day DMYD.B 1.97% DJIA 0.58% Russell 2K 0.91% Health Care/Life Sciences 1.52...

FinanzNachrichten

Diamyd Medical AB (publ): Diamyd Medical receives GMP certification and manufacturing authorization for biological investigational medicinal products for human use

Diamyd Medical today announced a significant advancement in the company's operations related to the manufacturing of biological medicines (biologics). The company has now received GMP...

Unlock all articles with a

Never miss news about Diamyd Medical

Track Diamyd Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Diamyd Medical competitors & trending companies

Browse news for competitors to Diamyd Medical and other trending companies.